Upcoming Global Web Symposia
Friday, March 25, 2011
11:30 a.m. - 1:00 p.m. EST
Course Description:This module of the course begins with a discussion of the current model for functional allosteric modulation in receptors and the three basic types of allosteric molecule of therapeutic interest: PAMs (Positive Allosteric Modulators), Allosteric Antagonists, and Allosteric Agonists. To completely characterize an allosteric molecule, three parameters must be estimated: a (effect on affinity), b (effect on efficacy) and tB (direct agonist effect). This module will discuss specific methods to do this. In addition, special considerations required for allosteric screens will be discussed.
Learning Objectives:This session is designed to solve a problem, namely the use of the functional models of allosteric function to characterize molecules in a system independent manner with parameters that are applicable to all systems and which can be used to predict allosteric effect in all systems.
This module also will discuss how to optimize assays for the discovery of (screening) and characterization (lead optimization ) of allosteric molecules
Instructor Information: Terry Kenakin Ph.D.
Professor, Department of Pharmacology
University of North Carolina School of Medicine
Chapel Hill NC
Instructor Biography:Terrence Kenakin, Ph.D., is Professor in the Department of Pharmacology, University of North Carolina, Chapel Hill. Until August of 2011, Dr. Kenakin was director of research at GlaxoSmithKline Research and Development laboratories at Research Triangle Park, NC where he optimized drug activity assay systems for the discovery and testing of. allosteric molecules mostly for the treatment of diabetes. Before starting the major stint of his drug discovery career at GSK, Dr. Kenakin was an associate scientist at Burroughs-Wellcome in the U.K. which he joined after a post-doctoral fellowship at University College London, U.K. Dr. Kenakin earned his Ph.D. in Pharmacology at the University of Alberta, Edmonton Canada.
Dr. Kenakin is a member of many editorial boards as well as Co-editor-in-Chief of the Journal of Receptors and Signal Transduction. In addition, he has authored numerous articles and has written eight books on pharmacology, including the popular "A Pharmacology Primer".
250 First Avenue Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425E: firstname.lastname@example.org
biological therapeutic productsbiomarkers & diagnosticsbiopharma strategybioprocess & manufacturingchemistryclinical trials & translational medicinedrug & device safety
drug discovery & developmentdrug targetsgenomicshealthcareit & informaticstechnology & tools for life sciencetherapeutic indications
conferencesreportsbarnett educational servicesconsultingpublications & eNewslettersprofessional services
executive teamtestimonialschi timelinemailing listcareers